Autolus Therapeutics plc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -7.6% | +140.1% | -5.3% | -3.1% | -5.4% | -4.6% | -3.4% | -8.2% | -11.0% | -10.5% | -6.4% | |
| – | -10.2% | +191.5% | -5.7% | -5.1% | -8.0% | -6.8% | -6.7% | -10.4% | -15.3% | -15.4% | -8.9% | |
| – | -6.7% | +217.0% | -6.9% | -7.1% | -65.4% | -57.9% | +29.3% | -30.4% | +20.9% | +25.7% | +30.9% | |
| – | -6.7% | +217.0% | -6.9% | -7.1% | -10.5% | -12.2% | -12.1% | -19.1% | -18.2% | -23.7% | -12.1% | |
| – | -97.5% | +2,862.8% | +19.5% | -97.3% | +4,758.0% | -70.3% | +448.9% | +16.2% | -17.0% | +13.8% | -48.5% | |
| – | -348.4% | – | – | – | – | +254.0% | +63.5% | +15.8% | +19.8% | +0.1% | +0.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | +0.8% | +3.7% | +56.8% | -2.3% | -4.2% | -2.3% | |
| – | +17.0% | +21.0% | +2.0% | +7.6% | +1.4% | +5.6% | -0.2% | +5.9% | +3.6% | +1.8% | +0.0% | |
| – | +19.2% | -1.7% | -7.0% | +28.3% | +15.8% | +9.7% | +2.3% | +21.9% | -11.6% | -13.4% | +8.2% | |
| – | -8.0% | -4.7% | -12.3% | -15.6% | -16.0% | -0.8% | +10.2% | +47.3% | +201.7% | -79.0% | +89.1% | |
| – | -84.4% | +1,258.3% | -21.5% | +29.1% | +38.9% | +126.4% | +21.3% | +102.8% | -71.9% | -39.3% | -27.0% | |
| – | -38.2% | +422.1% | -9.3% | -9.6% | -10.4% | -13.2% | -6.6% | -23.4% | -32.9% | -38.9% | -31.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +27.7% | +19.7% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.